[What can be done for patients with digestive cancer in 1999? Guidelines of the French Foundation of Digestive Cancerology (2nd part)].
Barbare
J C
JC
Bedenne
L
L
Bouché
O
O
Cadiot
G
G
Calais
G
G
de Calan
L
L
Conroy
T
T
Ducreux
M
M
Etienne
P L
PL
Elias
D
D
Faivre
J
J
Legoux
J L
JL
Maingon
P
P
Mornex
F
F
Nordlinger
B
B
Ollier
J C
JC
Peiffert
D
D
Pelletier
G
G
Rat
P
P
Rougier
P
P
Ruskone-Fourmestraux
A
A
Seitz
J F
JF
Triboulet
J P
JP
Trinchet
J C
JC
Ychou
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D004067:Digestive System Neoplasms / Q000473:pathology / Q000628:therapy*; D005602:France; D006801:Humans; D008207:Lymphatic Metastasis; D008223:Lymphoma / Q000628:therapy; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011182:Postoperative Care / Q000379:methods; D011300:Preoperative Care / Q000379:methods; D012004:Rectal Neoplasms / Q000628:therapy
D000970:Antineoplastic Agents
Que faire devant un cancer digestif en 1999? Recommandations de la Fondation Française de Cancérologie Digestive (2e partie).